Our People

Board of Directors

 

Scientific Advisory Board

 

Affiliate Members

The NYGC provides Affiliate Memberships to external academic researchers who have a significant interest in and commitment to the scientific life and work of the NYGC, and will contribute to and benefit from the NYGC’s mission.

Researchers who hold primary academic and/or clinical appointments at Institutional Founding Member and Institutional Associate Member organizations are eligible to be considered for an appointment as Affiliate Members.

The NYGC currently has 93 Affiliate Members, hailing from 16 academic institutions and medical centers. Please email Affiliate affiliate@nygenome.org if you are interested in applying to the program.

NYGC Affiliate Members

Cory Abate-Shen, PhD,
Columbia University
Schahram Akbarian, MD, PhD,
Icahn School of Medicine at Mount Sinai
Christopher Barbieri, MD, PhD,
Weill Cornell Medicine
Michael Berger, PhD,
Memorial Sloan Kettering Cancer Center
Richard Bonneau, PhD,
New York University
Kristen Brennand, PhD,
Icahn School of Medicine at Mount Sinai
Harmen J. Bussemaker, PhD,
Columbia University
Joseph Buxbaum, PhD,
Icahn School of Medicine at Mount Sinai
Andrea Califano, PhD,
Columbia University
Lewis Cantley, PhD,
Weill Cornell Medicine
Aravinda Chakravarti, PhD,
New York University
Alexander Charney, MD, PhD,
Icahn School of Medicine at Mount Sinai
Wendy Chung, MD, PhD,
Columbia University
Dalton Conley, PhD,
Princeton University
Isidro Cortes Ciriano, PhD,
European Bioinformatics Institute
Christopher Cunniff, MD,
Weill Cornell Medicine
Philip De Jager, MD, PhD,
Columbia University
Olivier Elemento, PhD,
Weill Cornell Medicine
Eleazar Eskin, PhD,
UCLA
Bishoy Morris Faltas, MD,
Weill Cornell Medicine
Howard A. Fine, MD,
Weill Cornell Medicine
Erin Flaherty, PhD,
Columbia University
Fieke Froeling, MD, PhD,
Cold Spring Harbor Laboratory
Kevin Gardner, MD, PhD,
Columbia University
Jellert Gaublomme, PhD,
Columbia University
Thomas R. Gingeras, PhD,
Cold Spring Harbor Laboratory
Alison Goate, DPhil,
Icahn School of Medicine at Mount Sinai
John Greally, MD, PhD,
Albert Einstein College of Medicine
Benjamin Greenbaum, PhD,
Memorial Sloan Kettering Cancer Center
Steven S. Gross, PhD,
Weill Cornell Medicine
Cheryl Y. Hayashi, PhD,
American Museum of Natural History
Liam Holt, PhD,
New York University
George Hripcsak, MD,
Columbia University
Benjamin Izar, MD, PhD,
Columbia University
Simon John, PhD,
Columbia University
Marko Jovanovic, PhD,
Columbia University
Eimear Kenny, PhD,
Icahn School of Medicine at Mount Sinai
Ekta Khurana, PhD,
Weill Cornell Medicine
Jennie Kline, PhD,
Columbia University
Andrew Kung, MD, PhD,
Memorial Sloan Kettering Cancer Center
Steven Kushner, MD, PhD,
Columbia University
Marc Ladanyi, MD,
Memorial Sloan Kettering Cancer Center
Gina Lee, PhD,
Weill Cornell Medicine
Todd Lencz, PhD,
Northwell Health
Ross Levine, MD,
Memorial Sloan Kettering Cancer Center
Steven Lipkin, MD, PhD,
Weill Cornell Medicine
Massimo Loda, MD,
Weill Cornell Medicine
David Lyden, MD, PhD,
Weill Cornell Medicine
Luciano Martelotto, PhD,
Harvard University
Christopher Mason, PhD,
Weill Cornell Medicine
W. Richard McCombie, PhD,
Cold Spring Harbor Laboratory
Ari Melnick, MD,
Weill Cornell Medicine
Vilas Menon, PhD,
Columbia University
JJ Miranda, PhD,
Barnard College
Bud Mishra, PhD,
New York University
Juan Miguel Mosquera, MD, MSc,
Weill Cornell Medicine
Parvathi A. Myer, MD,
Albert Einstein College of Medicine
Benjamin G. Neel, MD, PhD,
New York University
Kenneth Offit, MD,
Memorial Sloan Ketting Cancer Center
William Oh, MD,
Icahn School of Medicine at Mount Sinai
Ramon Parsons, MD, PhD,
Icahn School of Medicine at Mount Sinai
Chiraag D. Patel, MD,
Stony Brook University
Paz Polak, PhD,
Icahn School of Medicine at Mount Sinai
Scott Powers, PhD,
Stony Brook University
Molly Przeworski, PhD,
Columbia University
Raul Rabadan, PhD,
Columbia University
Ben Raphael, PhD,
Princeton University
Ed Reznik, PhD,
Memorial Sloan Kettering Cancer Center
Jeffrey Rosenfeld, PhD,
Rutgers
M. Elizabeth Ross, MD, PhD,
Weill Cornell Medicine
Kevin A Roth, MD, PhD,
Columbia University
Panos Roussos, MD, PhD,
Icahn School of Medicine at Mount Sinai
Anil Rustgi, MD,
Columbia University
Charles Sawyers, MD,
Memorial Sloan Kettering Cancer Center
Nikolaus Schultz, PhD,
Memorial Sloan Kettering Cancer Center
Sohrab P. Shah, PhD,
Memorial Sloan Kettering Cancer Center
Wen H. Shen, PhD,
Weill Cornell Medicine
Yufeng Shen, PhD,
Columbia University
Kosaku Shinoda, PhD,
Albert Einstein College of Medicine
Adam Siepel, PhD,
Cold Spring Harbor Laboratory
Jane Skok, PhD,
New York University
Barry Sleckman, MD, PhD,
Weill Cornell Medicine
Matija Snuderl, MD,
New York University
Sohail Tavazoie, MD, PhD,
The Rockefeller University
Alison Taylor, PhD,
Columbia University
Barry S. Taylor, PhD,
Loxo Oncology, Eli Lilly
David Tuveson, MD, PhD,
Cold Spring Harbor Laboratory
Krishna Veeramah, PhD,
Stony Brook University
Thomas Vierbuchen, PhD,
Memorial Sloan Kettering Cancer Center
Julia Wattacheril, MD,
Columbia University
Hynek Wichterle, PhD,
Columbia University
Youzhi Xu, PhD
Memorial Sloan Kettering Cancer Center
Itai Yanai, PhD,
New York University
Chaolin Zhang, PhD,
Columbia University

Scientific Working Groups

The NYGC has established scientific working groups with the objective of bringing together NYGC researchers and the scientific community to advance disease-based research in areas where our strengths and experience can make a significant difference.

Genome Center Cancer Group
The Genome Center Cancer Group (GCCG), led by Harold Varmus, MD, NYGC and Weill Cornell Medicine, and Charles Sawyers, MD, Memorial Sloan Kettering Cancer Center, is composed of clinicians and cancer researchers from NYGC’s member institutions, including 8 NCI-Designated Cancer Centers. The GCCG launched Polyethnic-1000, a project to study cancer in New York’s ethnically diverse, underserved patient populations. The group is also spearheading the multi-institutional Very Rare Cancer Consortium, a research cohort focused on understanding the genetic causes for rare, understudied cancers.

Computational Cancer Genomics Working Group
Led by Simon Tavaré, PhD, NYGC and Columbia University, and Sohrab Shah, PhD, Memorial Sloan Kettering Cancer Center and modeled after our GCCG and Polyethnic-1000 initiatives, the Computational Cancer Genomics Working Group aims to build collaborations that apply novel statistical approaches and population-level analyses to major cohorts in cancer genomics and develop new computational tools and frameworks for emerging and potentially transformative technologies such as Direct Library Preparation Plus.

Enabling Innovation Working Group
The Enabling Innovation Working Group, led by NYGC Senior Scientific Director of Cancer Genomics Samuel Aparicio, PhD, brings together researchers from our Institutional Founding Members, NYGC faculty and senior faculty, NYGC technology development and computational scientists, and affiliate members to build collaborative initiatives in gene editing and functional genomics, single cell and spatial genomics, and innovative computational methods necessary to understand the underlying biology and mechanisms of disease to advance precision medicine.

Neurodegenerative Disease Working Group
The NYGC is leveraging the success of the Center for Genomics of Neurodegenerative Disease (CGND) to extend our work across a range of neurodegenerative diseases that have pathways in common with ALS, including dementia, Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease, and Huntington’s disease. The Neurodegenerative Disease Working Group is co-led by Thomas Lehner, PhD, MPH, NYGC and Hemali Phatnani, PhD, NYGC and Columbia University, with the objective of bringing together researchers from our Institutional Founding Members, NYGC faculty and senior faculty, NYGC technology development and computational scientists, and affiliate members to build partnerships and programs to better understand the biological underpinnings and molecular mechanisms driving neurodegenerative disease.

Neuropsychiatric Disease Working Group
The Neuropsychiatric Disease Working Group, led by Thomas Lehner, PhD, MPH, NYGC brings together researchers from our Institutional Founding Members, NYGC faculty, senior faculty, NYGC technology development and computational scientists, and affiliate members to discuss the underlying disease mechanisms in neuropsychiatric disease. The group is building off the large dataset produced by NYGC as part of the Centers for Common Disease Genomics, funded by the NHGRI. As part of this effort, NYGC generated whole genome sequencing data on over 37,000 individuals from families with at least one member affected by autism spectrum disorder. Currently the group is working on a number of initiatives studying the biological underpinnings of neuropsychiatric disorders including bipolar disorder, schizophrenia and other psychosis-related disorders.

Population Genomics and Statistical Genetics Working Group
The Population Genomics and Statistical Genetics Working Group is led by David Knowles, PhD, NYGC and Adam Siepel, PhD, Cold Spring Harbor Laboratory. This group brings together scientists to discuss the development and investigation into the human population genomic data that underpins and informs all disease-focused research. The groups interest span a number of research areas, including long read sequencing, social health science, ancestry-based genomics, as well as the genome-wide computational approaches that allow us to interpret human genome and transcriptome data.